CNTX (STOCKS)
Context Therapeutics Inc. Common Stock
$0.650000
-0.740000 (-53.24%)
Prev close: $1.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Martin A. Lehr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $62.22M
- Employees
- 9
- P/E (TTM)
- -1.59
- P/B (TTM)
- 1.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.09 | $-0.12 | +0.0297 | +24.81% |
|
Dec 2025 (Q4)
|
$-0.14 | $-0.11 | -0.0318 | -29.39% |
|
Sep 2025 (Q3)
|
$-0.10 | $-0.10 | -0.0039 | -4.06% |
|
Jun 2025 (Q2)
|
$-0.09 | $-0.06 | -0.0276 | -44.23% |
Financial Statements
| Operating Income/Loss | -$43.52M |
| Income/Loss From Continuing Operations After Tax | -$40.23M |
| Income/Loss From Continuing Operations Before Tax | -$40.23M |
| Net Income/Loss | -$40.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$40.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$40.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.42 |
| Diluted Earnings Per Share | -$0.42 |
| Basic Average Shares | 285,555,177 |
| Diluted Average Shares | 285,555,177 |
| Assets | $58.86M |
| Current Assets | $58.52M |
| Noncurrent Assets | $342.28K |
| Fixed Assets | $62.23K |
| Other Non-current Assets | $280.05K |
| Liabilities | $6.66M |
| Current Liabilities | $6.53M |
| Accounts Payable | $2.47M |
| Wages | $438.28K |
| Other Current Liabilities | $3.63M |
| Noncurrent Liabilities | $122.37K |
| Equity | $52.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $52.20M |
| Liabilities And Equity | $58.86M |
| Net Cash Flow From Operating Activities | -$32.79M |
| Net Cash Flow From Operating Activities, Continuing | -$32.79M |
| Net Cash Flow From Investing Activities | -$2.04M |
| Net Cash Flow From Investing Activities, Continuing | -$2.04M |
| Net Cash Flow From Financing Activities | $11.47M |
| Net Cash Flow From Financing Activities, Continuing | $11.47M |
| Net Cash Flow | -$23.36M |
| Net Cash Flow, Continuing | -$23.36M |
| Comprehensive Income/Loss | -$40.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$40.23M |
| Other Comprehensive Income/Loss | $0.00 |